What Is Causing G1 Therapeutics Inc. (GTHX) Stock To rising In aftermarket Trading?
G1 Therapeutics, Inc. (Nasdaq: GTHX) a commercial-stage biopharmaceutical company specializing in the discovery, development and delivery of next generation therapies that enhance the lives of patients affected with cancer, announced corporate and financial update for the first quarter completed on March 31, 2021. GTHX stock increased substantially adjacent to the news. At last check in […]
